Skip to main content
Top
Published in: Heart Failure Reviews 6/2022

20-07-2022 | Myotonic Dystrophy

Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging

Authors: Georgios M. Alexandridis, Efstathios D. Pagourelias, Nikolaos Fragakis, Maria Kyriazi, Efthymia Vargiami, Dimitrios Zafeiriou, Vassilios P. Vassilikos

Published in: Heart Failure Reviews | Issue 6/2022

Login to get access

Abstract

Neuromuscular diseases (NMDs) include a broad spectrum of disorders that affect motor unit in every possible site, extending from the cell body of peripheral nerves to the muscle. The different lesion sites make this group of inherited disorders difficult to diagnose. Many NMDs, especially those involving skeletal muscles, can present significant cardiovascular complications, ranging from rhythm disturbances to the development of dilated or hypertrophic cardiomyopathy. Heart disease represents a major cause of morbidity and mortality among NMD patients, underlining the vital need for further familiarization with the pathogenesis and assessment of cardiac involvement. Cardiovascular imaging is the cornerstone for the evaluation of heart disorders in NMDs, with conventional echocardiography still offering a portable, affordable, and easily accessible solution. Meanwhile, newer echocardiographic techniques such as speckle tracking imaging in combination with cardiac magnetic resonance add new insights into further substrate characterization. The purpose of this review is to offer a brief presentation of the main NMDs and their cardiovascular complications, as well as the presentation of data that highlight the importance of cardiovascular imaging in early diagnosis, monitoring, and prognosis of these patients. Lastly, the authors provide a simple guide about which clinical features, imaging findings, and follow-up plan to adopt in each myopathic disorder.
Literature
2.
go back to reference Korinthenberg R (2017) Neuromuscular disorders in children and adolescents. Neuropediatrics 48(4):209–210PubMedCrossRef Korinthenberg R (2017) Neuromuscular disorders in children and adolescents. Neuropediatrics 48(4):209–210PubMedCrossRef
3.
go back to reference Askanas V, King Engel W (2015) Update on neuromuscular diseases: pathology and molecular pathogenesis. Biochim Biophys Acta 1852(4):561–562PubMedCrossRef Askanas V, King Engel W (2015) Update on neuromuscular diseases: pathology and molecular pathogenesis. Biochim Biophys Acta 1852(4):561–562PubMedCrossRef
4.
go back to reference Sáez A, Acha B, Montero-Sánchez A, Rivas E, Escudero LM, Serrano C (2013) Neuromuscular disease classification system. J Biomed Opt 18(6):066017PubMedCrossRef Sáez A, Acha B, Montero-Sánchez A, Rivas E, Escudero LM, Serrano C (2013) Neuromuscular disease classification system. J Biomed Opt 18(6):066017PubMedCrossRef
5.
go back to reference Ismail H, Raynor E, Zimetbaum P (2017) Neuromuscular disorders and the role of the clinical electrophysiologist. JACC Clin Electrophysiol 3(10):1069–1079PubMedCrossRef Ismail H, Raynor E, Zimetbaum P (2017) Neuromuscular disorders and the role of the clinical electrophysiologist. JACC Clin Electrophysiol 3(10):1069–1079PubMedCrossRef
6.
go back to reference Feingold B, Mahle WT, Auerbach S, Clemens P, Domenighetti AA, Jefferies JL, Judge DP, Lal AK, Markham LW, Parks WJ, Tsuda T, Wang PJ, Yoo SJ (2017) Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the american heart association. Circulation 136(13):e200–e231PubMedCrossRef Feingold B, Mahle WT, Auerbach S, Clemens P, Domenighetti AA, Jefferies JL, Judge DP, Lal AK, Markham LW, Parks WJ, Tsuda T, Wang PJ, Yoo SJ (2017) Management of cardiac involvement associated with neuromuscular diseases: a scientific statement from the american heart association. Circulation 136(13):e200–e231PubMedCrossRef
7.
go back to reference Arbustini E, Di Toro A, Giuliani L, Favalli V, Narula N, Grasso M (2018) Cardiac phenotypes in hereditary muscle disorders: JACC state-of-the-art review. J Am Coll Cardiol 72(20):2485–2506PubMedCrossRef Arbustini E, Di Toro A, Giuliani L, Favalli V, Narula N, Grasso M (2018) Cardiac phenotypes in hereditary muscle disorders: JACC state-of-the-art review. J Am Coll Cardiol 72(20):2485–2506PubMedCrossRef
8.
go back to reference Limpitikul W, Ong CS, Tomaselli GF (2017) Neuromuscular disease: cardiac manifestations and sudden death risk. Card Electrophysiol Clin 9(4):731–747PubMedCrossRef Limpitikul W, Ong CS, Tomaselli GF (2017) Neuromuscular disease: cardiac manifestations and sudden death risk. Card Electrophysiol Clin 9(4):731–747PubMedCrossRef
9.
go back to reference Sommerville RB, Vincenti MG, Winborn K, Casey A, Stitziel NO, Connolly AM, Mann DL (2017) Diagnosis and management of adult hereditary cardio-neuromuscular disorders: a model for the multidisciplinary care of complex genetic disorders. Trends Cardiovasc Med 27(1):51–58PubMedCrossRef Sommerville RB, Vincenti MG, Winborn K, Casey A, Stitziel NO, Connolly AM, Mann DL (2017) Diagnosis and management of adult hereditary cardio-neuromuscular disorders: a model for the multidisciplinary care of complex genetic disorders. Trends Cardiovasc Med 27(1):51–58PubMedCrossRef
10.
go back to reference Rochitte CE, Liberato G, Silva MC (2019) Comprehensive assessment of cardiac involvement in muscular dystrophies by cardiac MR imaging. Magn Reson Imaging Clin N Am 27(3):521–531PubMedCrossRef Rochitte CE, Liberato G, Silva MC (2019) Comprehensive assessment of cardiac involvement in muscular dystrophies by cardiac MR imaging. Magn Reson Imaging Clin N Am 27(3):521–531PubMedCrossRef
11.
go back to reference Power LC, O’Grady GL, Hornung TS, Jefferies C, Gusso S, Hofman PL (2018) Imaging the heart to detect cardiomyopathy in Duchenne muscular dystrophy: a review. Neuromuscul Disord 28(9):717–730PubMedCrossRef Power LC, O’Grady GL, Hornung TS, Jefferies C, Gusso S, Hofman PL (2018) Imaging the heart to detect cardiomyopathy in Duchenne muscular dystrophy: a review. Neuromuscul Disord 28(9):717–730PubMedCrossRef
12.
go back to reference Poonja S, Power A, Mah JK, Fine NM, Greenway SC (2018) Current cardiac imaging approaches in Duchenne muscular dystrophy. J Clin Neuromuscul Dis 20(2):85–93PubMedCrossRef Poonja S, Power A, Mah JK, Fine NM, Greenway SC (2018) Current cardiac imaging approaches in Duchenne muscular dystrophy. J Clin Neuromuscul Dis 20(2):85–93PubMedCrossRef
13.
go back to reference Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M, Santarone M (2002) Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89(7):838–841PubMedCrossRef Corrado G, Lissoni A, Beretta S, Terenghi L, Tadeo G, Foglia-Manzillo G, Tagliagambe LM, Spata M, Santarone M (2002) Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am J Cardiol 89(7):838–841PubMedCrossRef
14.
go back to reference Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112(18):2799–2804PubMedCrossRef Jefferies JL, Eidem BW, Belmont JW, Craigen WJ, Ware SM, Fernbach SD, Neish SR, Smith EO, Towbin JA (2005) Genetic predictors and remodeling of dilated cardiomyopathy in muscular dystrophy. Circulation 112(18):2799–2804PubMedCrossRef
15.
go back to reference Pagourelias ED, Mirea O, Vovas G, Duchenne J, Michalski B, Van Cleemput J, Bogaert J, Vassilikos VP, Voigt JU (2019) Relation of regional myocardial structure and function in hypertrophic cardiomyopathy and amyloidosis: a combined two-dimensional speckle tracking and cardiovascular magnetic resonance analysis. Eur Heart J Cardiovasc Imaging 20(4):426–437PubMedCrossRef Pagourelias ED, Mirea O, Vovas G, Duchenne J, Michalski B, Van Cleemput J, Bogaert J, Vassilikos VP, Voigt JU (2019) Relation of regional myocardial structure and function in hypertrophic cardiomyopathy and amyloidosis: a combined two-dimensional speckle tracking and cardiovascular magnetic resonance analysis. Eur Heart J Cardiovasc Imaging 20(4):426–437PubMedCrossRef
16.
go back to reference Yajima R, Kataoka A, Takahashi A, Uehara M, Saito M, Yamaguchi C, Lee K, Komuro I, Funabashi N (2012) Distinguishing focal fibrotic lesions and non-fibrotic lesions in hypertrophic cardiomyopathy by assessment of regional myocardial strain using two-dimensional speckle tracking echocardiography: comparison with multislice CT. Int J Cardiol 158(3):423–432PubMedCrossRef Yajima R, Kataoka A, Takahashi A, Uehara M, Saito M, Yamaguchi C, Lee K, Komuro I, Funabashi N (2012) Distinguishing focal fibrotic lesions and non-fibrotic lesions in hypertrophic cardiomyopathy by assessment of regional myocardial strain using two-dimensional speckle tracking echocardiography: comparison with multislice CT. Int J Cardiol 158(3):423–432PubMedCrossRef
17.
go back to reference Mirea O, Duchenne J, Voigt JU (2016) Recent advances in echocardiography: strain and strain rate imaging. F1000Res 5: F1000 Faculty Rev-787. Published 2016 Apr 29 Mirea O, Duchenne J, Voigt JU (2016) Recent advances in echocardiography: strain and strain rate imaging. F1000Res 5: F1000 Faculty Rev-787. Published 2016 Apr 29
18.
go back to reference Amedro P, Vincenti M, De La Villeon G, Lavastre K, Barrea C, Guillaumont S, Bredy C, Gamon L, Meli AC, Cazorla O, Fauconnier J, Meyer P, Rivier F, Adda J, Mura T, Lacampagne A (2019) Speckle-tracking echocardiography in children with Duchenne muscular dystrophy: a prospective multicenter controlled cross-sectional study. J Am Soc Echocardiogr 32(3):412–422PubMedCrossRef Amedro P, Vincenti M, De La Villeon G, Lavastre K, Barrea C, Guillaumont S, Bredy C, Gamon L, Meli AC, Cazorla O, Fauconnier J, Meyer P, Rivier F, Adda J, Mura T, Lacampagne A (2019) Speckle-tracking echocardiography in children with Duchenne muscular dystrophy: a prospective multicenter controlled cross-sectional study. J Am Soc Echocardiogr 32(3):412–422PubMedCrossRef
19.
go back to reference Song G, Zhang J, Wang X, Zhang X, Sun F, Yu X (2020) Usefulness of speckle-tracking echocardiography for early detection in children with Duchenne muscular dystrophy: a meta-analysis and trial sequential analysis. Cardiovasc Ultrasound 18(1):26PubMedPubMedCentralCrossRef Song G, Zhang J, Wang X, Zhang X, Sun F, Yu X (2020) Usefulness of speckle-tracking echocardiography for early detection in children with Duchenne muscular dystrophy: a meta-analysis and trial sequential analysis. Cardiovasc Ultrasound 18(1):26PubMedPubMedCentralCrossRef
20.
go back to reference Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67(21):2533–2546PubMedCrossRef Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67(21):2533–2546PubMedCrossRef
21.
go back to reference Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK (2018) Cardiac management of the patient with Duchenne muscular dystrophy. Pediatrics 142(Suppl 2):S72–S81PubMedCrossRef Buddhe S, Cripe L, Friedland-Little J, Kertesz N, Eghtesady P, Finder J, Hor K, Judge DP, Kinnett K, McNally EM, Raman S, Thompson WR, Wagner KR, Olson AK (2018) Cardiac management of the patient with Duchenne muscular dystrophy. Pediatrics 142(Suppl 2):S72–S81PubMedCrossRef
22.
go back to reference Mavrogeni S, Markousis-Mavrogenis G, Papavasiliou A, Kolovou G (2015) Cardiac involvement in Duchenne and Becker muscular dystrophy. World J Cardiol 7(7):410–414PubMedPubMedCentralCrossRef Mavrogeni S, Markousis-Mavrogenis G, Papavasiliou A, Kolovou G (2015) Cardiac involvement in Duchenne and Becker muscular dystrophy. World J Cardiol 7(7):410–414PubMedPubMedCentralCrossRef
23.
go back to reference Mavrogeni S, Papavasiliou A, Giannakopoulou K, Markousis-Mavrogenis G, Pons MR, Karanasios E, Nikas I, Papadopoulos G, Kolovou G, Chrousos GP (2017) Oedema-fibrosis in Duchenne muscular dystrophy: role of cardiovascular magnetic resonance imaging. Eur J Clin Invest 47(12). https://doi.org/10.1111/eci.12843 Mavrogeni S, Papavasiliou A, Giannakopoulou K, Markousis-Mavrogenis G, Pons MR, Karanasios E, Nikas I, Papadopoulos G, Kolovou G, Chrousos GP (2017) Oedema-fibrosis in Duchenne muscular dystrophy: role of cardiovascular magnetic resonance imaging. Eur J Clin Invest 47(12). https://​doi.​org/​10.​1111/​eci.​12843
24.
go back to reference Brunklaus A, Parish E, Muntoni F, Scuplak S, Tucker SK, Fenton M, Hughes ML, Manzur AY (2015) The value of cardiac MRI versus echocardiography in the pre-operative assessment of patients with Duchenne muscular dystrophy. Eur J Paediatr Neurol 19(4):395–401PubMedCrossRef Brunklaus A, Parish E, Muntoni F, Scuplak S, Tucker SK, Fenton M, Hughes ML, Manzur AY (2015) The value of cardiac MRI versus echocardiography in the pre-operative assessment of patients with Duchenne muscular dystrophy. Eur J Paediatr Neurol 19(4):395–401PubMedCrossRef
25.
go back to reference Nikolaidou C, Karamitsos TD (2020) Cardiac magnetic resonance in patients with muscular dystrophies: strengthening the data [published online ahead of print, 2020 Jun 10]. Eur J Prev Cardiol 2047487320932693 Nikolaidou C, Karamitsos TD (2020) Cardiac magnetic resonance in patients with muscular dystrophies: strengthening the data [published online ahead of print, 2020 Jun 10]. Eur J Prev Cardiol 2047487320932693
26.
go back to reference Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, Starling Filho GM, Ferreira Rde A, Zatz M, Rochitte CE (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49(18):1874–1879PubMedCrossRef Silva MC, Meira ZM, Gurgel Giannetti J, da Silva MM, Campos AF, Barbosa Mde M, Starling Filho GM, Ferreira Rde A, Zatz M, Rochitte CE (2007) Myocardial delayed enhancement by magnetic resonance imaging in patients with muscular dystrophy. J Am Coll Cardiol 49(18):1874–1879PubMedCrossRef
27.
go back to reference Tandon A, Villa CR, Hor KN, Jefferies JL, Gao Z, Towbin JA, Wong BL, Mazur W, Fleck RJ, Sticka JJ, Benson DW, Taylor MD (2015) Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in Duchenne muscular dystrophy. J Am Heart Assoc 4(4):e001338PubMedPubMedCentralCrossRef Tandon A, Villa CR, Hor KN, Jefferies JL, Gao Z, Towbin JA, Wong BL, Mazur W, Fleck RJ, Sticka JJ, Benson DW, Taylor MD (2015) Myocardial fibrosis burden predicts left ventricular ejection fraction and is associated with age and steroid treatment duration in Duchenne muscular dystrophy. J Am Heart Assoc 4(4):e001338PubMedPubMedCentralCrossRef
28.
go back to reference Menon SC, Etheridge SP, Liesemer KN, Williams RV, Bardsley T, Heywood MC, Puchalski MD (2014) Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy. Pediatr Cardiol 35(7):1279–1285PubMedCrossRef Menon SC, Etheridge SP, Liesemer KN, Williams RV, Bardsley T, Heywood MC, Puchalski MD (2014) Predictive value of myocardial delayed enhancement in Duchenne muscular dystrophy. Pediatr Cardiol 35(7):1279–1285PubMedCrossRef
29.
go back to reference Silva MC, Magalhães TA, Meira ZM, Rassi CH, Andrade AC, Gutierrez PS, Azevedo CF, Gurgel-Giannetti J, Vainzof M, Zatz M, Kalil-Filho R, Rochitte CE (2017) Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial. JAMA Cardiol 2(2):190–199PubMedCrossRef Silva MC, Magalhães TA, Meira ZM, Rassi CH, Andrade AC, Gutierrez PS, Azevedo CF, Gurgel-Giannetti J, Vainzof M, Zatz M, Kalil-Filho R, Rochitte CE (2017) Myocardial fibrosis progression in Duchenne and Becker muscular dystrophy: a randomized clinical trial. JAMA Cardiol 2(2):190–199PubMedCrossRef
30.
go back to reference Lang SM, Alsaied T, Khoury PR, Ryan TD, Taylor MD (2021) Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement. Int J Cardiovasc Imaging 37(2):635–642PubMedCrossRef Lang SM, Alsaied T, Khoury PR, Ryan TD, Taylor MD (2021) Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement. Int J Cardiovasc Imaging 37(2):635–642PubMedCrossRef
31.
go back to reference Soslow JH, Damon BM, Saville BR, Lu Z, Burnette WB, Lawson MA, Parra DA, Sawyer DB, Markham LW (2015) Evaluation of post-contrast myocardial t1 in Duchenne muscular dystrophy using cardiac magnetic resonance imaging. Pediatr Cardiol 36(1):49–56PubMedCrossRef Soslow JH, Damon BM, Saville BR, Lu Z, Burnette WB, Lawson MA, Parra DA, Sawyer DB, Markham LW (2015) Evaluation of post-contrast myocardial t1 in Duchenne muscular dystrophy using cardiac magnetic resonance imaging. Pediatr Cardiol 36(1):49–56PubMedCrossRef
32.
go back to reference Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, DMD Care Considerations Working Group (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9(1):77–93 Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, DMD Care Considerations Working Group (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9(1):77–93
33.
go back to reference Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR, DMD Care Considerations Working Group (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management [published correction appears in lancet neurol 2018 Apr 4. Lancet Neurol 17(3):251–267 Birnkrant DJ, Bushby K, Bann CM, Apkon SD, Blackwell A, Brumbaugh D, Case LE, Clemens PR, Hadjiyannakis S, Pandya S, Street N, Tomezsko J, Wagner KR, Ward LM, Weber DR, DMD Care Considerations Working Group (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management [published correction appears in lancet neurol 2018 Apr 4. Lancet Neurol 17(3):251–267
35.
go back to reference Meyers TA, Townsend D (2019) Cardiac pathophysiology and the future of cardiac therapies in Duchenne muscular dystrophy. Int J Mol Sci 20(17):4098PubMedCentralCrossRef Meyers TA, Townsend D (2019) Cardiac pathophysiology and the future of cardiac therapies in Duchenne muscular dystrophy. Int J Mol Sci 20(17):4098PubMedCentralCrossRef
36.
go back to reference McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Groh WJ, Hoffman EP, Judge DP, Kertesz N, Kinnett K, Kirsch R, Metzger JM, Pearson GD, Rafael-Fortney JA, Raman SV, Spurney CF, Targum SL, Wagner KR, Markham LW, Working Group of the National Heart, Lung, and Blood Institute (2015) Contemporary cardiac issues in Duchenne muscular dystrophy. working group of the national heart, lung, and blood institute in collaboration with parent project muscular dystrophy [published correction appears in circulation. 2015 Jun 23; 131(25): e539. Groh, William J [added]. Circulation 131(18):1590–1598 McNally EM, Kaltman JR, Benson DW, Canter CE, Cripe LH, Duan D, Finder JD, Groh WJ, Hoffman EP, Judge DP, Kertesz N, Kinnett K, Kirsch R, Metzger JM, Pearson GD, Rafael-Fortney JA, Raman SV, Spurney CF, Targum SL, Wagner KR, Markham LW, Working Group of the National Heart, Lung, and Blood Institute (2015) Contemporary cardiac issues in Duchenne muscular dystrophy. working group of the national heart, lung, and blood institute in collaboration with parent project muscular dystrophy [published correction appears in circulation. 2015 Jun 23; 131(25): e539. Groh, William J [added]. Circulation 131(18):1590–1598
38.
go back to reference Siegel B, Olivieri L, Gordish-Dressman H, Spurney CF (2018) Myocardial strain using cardiac MR feature tracking and speckle tracking echocardiography in Duchenne muscular dystrophy patients. Pediatr Cardiol 39(3):478–483PubMedCrossRef Siegel B, Olivieri L, Gordish-Dressman H, Spurney CF (2018) Myocardial strain using cardiac MR feature tracking and speckle tracking echocardiography in Duchenne muscular dystrophy patients. Pediatr Cardiol 39(3):478–483PubMedCrossRef
39.
go back to reference Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26(3):271–277PubMedCrossRef Nigro G, Comi LI, Politano L, Bain RJ (1990) The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26(3):271–277PubMedCrossRef
40.
go back to reference Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM, DMD Care Considerations Working Group (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17(4):347–361 Birnkrant DJ, Bushby K, Bann CM, Alman BA, Apkon SD, Blackwell A, Case LE, Cripe L, Hadjiyannakis S, Olson AK, Sheehan DW, Bolen J, Weber DR, Ward LM, DMD Care Considerations Working Group (2018) Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management. Lancet Neurol 17(4):347–361
42.
go back to reference Yilmaz A, Sechtem U (2012) Republished education in heart: cardiac involvement in muscular dystrophy: advances in diagnosis and therapy. Postgrad Med J 88(1039):290–299PubMedCrossRef Yilmaz A, Sechtem U (2012) Republished education in heart: cardiac involvement in muscular dystrophy: advances in diagnosis and therapy. Postgrad Med J 88(1039):290–299PubMedCrossRef
43.
go back to reference Finsterer J, Stöllberger C (2000) Cardiac involvement in primary myopathies. Cardiology 94(1):1–11PubMedCrossRef Finsterer J, Stöllberger C (2000) Cardiac involvement in primary myopathies. Cardiology 94(1):1–11PubMedCrossRef
44.
go back to reference Yilmaz A, Gdynia HJ, Baccouche H, Mahrholdt H, Meinhardt G, Basso C, Thiene G, Sperfeld AD, Ludolph AC, Sechtem U (2008) Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 10(1):50PubMedPubMedCentralCrossRef Yilmaz A, Gdynia HJ, Baccouche H, Mahrholdt H, Meinhardt G, Basso C, Thiene G, Sperfeld AD, Ludolph AC, Sechtem U (2008) Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 10(1):50PubMedPubMedCentralCrossRef
45.
go back to reference Grigoratos C, Aimo A, Barison A, Castiglione V, Todiere G, Ricci G, Siciliano G, Emdin M (2020) Cardiac magnetic resonance in patients with muscular dystrophies [published online ahead of print, 2020 May 16]. Eur J Prev Cardiol 2047487320923052 Grigoratos C, Aimo A, Barison A, Castiglione V, Todiere G, Ricci G, Siciliano G, Emdin M (2020) Cardiac magnetic resonance in patients with muscular dystrophies [published online ahead of print, 2020 May 16]. Eur J Prev Cardiol 2047487320923052
46.
go back to reference Florian A, Ludwig A, Rösch S, Yildiz H, Sechtem U, Yilmaz A (2014) Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Eur Heart J Cardiovasc Imaging 15(9):1004–1012PubMedCrossRef Florian A, Ludwig A, Rösch S, Yildiz H, Sechtem U, Yilmaz A (2014) Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging. Eur Heart J Cardiovasc Imaging 15(9):1004–1012PubMedCrossRef
47.
go back to reference Marty B, Gilles R, Toussaint M, Béhin A, Stojkovic T, Eymard B, Carlier PG, Wahbi K (2019) Comprehensive evaluation of structural and functional myocardial impairments in Becker muscular dystrophy using quantitative cardiac magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 20(8):906–915PubMedCrossRef Marty B, Gilles R, Toussaint M, Béhin A, Stojkovic T, Eymard B, Carlier PG, Wahbi K (2019) Comprehensive evaluation of structural and functional myocardial impairments in Becker muscular dystrophy using quantitative cardiac magnetic resonance imaging. Eur Heart J Cardiovasc Imaging 20(8):906–915PubMedCrossRef
48.
go back to reference Bushby K, Muntoni F, Bourke JP (2003) 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th, June 2002 Naarden, the Netherlands. Neuromuscul Disord 13(2):166–172 Bushby K, Muntoni F, Bourke JP (2003) 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th, June 2002 Naarden, the Netherlands. Neuromuscul Disord 13(2):166–172
49.
go back to reference Walton JN, Nattrass FJ (1954) On the classification, natural history and treatment of the myopathies. Brain 77(2):169–231PubMedCrossRef Walton JN, Nattrass FJ (1954) On the classification, natural history and treatment of the myopathies. Brain 77(2):169–231PubMedCrossRef
50.
go back to reference Liewluck T, Milone M (2018) Untangling the complexity of limb-girdle muscular dystrophies. Muscle Nerve 58(2):167–177PubMedCrossRef Liewluck T, Milone M (2018) Untangling the complexity of limb-girdle muscular dystrophies. Muscle Nerve 58(2):167–177PubMedCrossRef
51.
go back to reference Wicklund MP (2019) The limb-girdle muscular dystrophies continuum (minneap minn) 25(6):1599–1618 Wicklund MP (2019) The limb-girdle muscular dystrophies continuum (minneap minn) 25(6):1599–1618
52.
go back to reference Angelini C, Giaretta L, Marozzo R (2018) An update on diagnostic options and considerations in limb-girdle dystrophies. Expert Rev Neurother 18(9):693–703PubMedCrossRef Angelini C, Giaretta L, Marozzo R (2018) An update on diagnostic options and considerations in limb-girdle dystrophies. Expert Rev Neurother 18(9):693–703PubMedCrossRef
53.
go back to reference Angelini C (2020) LGMD. Identification, description and classification. Acta Myol 39(4):207–217 Angelini C (2020) LGMD. Identification, description and classification. Acta Myol 39(4):207–217
54.
go back to reference Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, Jette N (2016) A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci 43(1):163–177PubMedCrossRef Mah JK, Korngut L, Fiest KM, Dykeman J, Day LJ, Pringsheim T, Jette N (2016) A systematic review and meta-analysis on the epidemiology of the muscular dystrophies. Can J Neurol Sci 43(1):163–177PubMedCrossRef
55.
go back to reference Bushby KM (1995) Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC consortium on limb-girdle dystrophies. Neuromuscul Disord 5(1):71–74PubMedCrossRef Bushby KM (1995) Diagnostic criteria for the limb-girdle muscular dystrophies: report of the ENMC consortium on limb-girdle dystrophies. Neuromuscul Disord 5(1):71–74PubMedCrossRef
56.
go back to reference Bushby KM, Beckmann JS (1995) The limb-girdle muscular dystrophies–proposal for a new nomenclature. Neuromuscul Disord 5(4):337–343PubMedCrossRef Bushby KM, Beckmann JS (1995) The limb-girdle muscular dystrophies–proposal for a new nomenclature. Neuromuscul Disord 5(4):337–343PubMedCrossRef
57.
go back to reference Georganopoulou DG, Moisiadis VG, Malik FA, Mohajer A, Dashevsky TM, Wuu ST, Hu CK (2021) A journey with LGMD: from protein abnormalities to patient. Protein J 1–23 Georganopoulou DG, Moisiadis VG, Malik FA, Mohajer A, Dashevsky TM, Wuu ST, Hu CK (2021) A journey with LGMD: from protein abnormalities to patient. Protein J 1–23
58.
go back to reference Straub V, Murphy A, Udd B, LGMD workshop study group, (2018) 229th ENMC international workshop: limb girdle muscular dystrophies - nomenclature and reformed classification Naarden, the Netherlands, 17–19 March 2017. Neuromuscul Disord 28(8):702–710PubMedCrossRef Straub V, Murphy A, Udd B, LGMD workshop study group, (2018) 229th ENMC international workshop: limb girdle muscular dystrophies - nomenclature and reformed classification Naarden, the Netherlands, 17–19 March 2017. Neuromuscul Disord 28(8):702–710PubMedCrossRef
59.
go back to reference Verhaert D, Richards K, Rafael-Fortney JA, Raman SV (2011) Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging 4(1):67–76PubMedPubMedCentralCrossRef Verhaert D, Richards K, Rafael-Fortney JA, Raman SV (2011) Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations. Circ Cardiovasc Imaging 4(1):67–76PubMedPubMedCentralCrossRef
60.
go back to reference Gaul C, Deschauer M, Tempelmann C, Vielhaber S, Klein HU, Heinze HJ, Zierz S, Grothues F (2006) Cardiac involvement in limb-girdle muscular dystrophy 2I : conventional cardiac diagnostic and cardiovascular magnetic resonance. J Neurol 253(10):1317–1322PubMedCrossRef Gaul C, Deschauer M, Tempelmann C, Vielhaber S, Klein HU, Heinze HJ, Zierz S, Grothues F (2006) Cardiac involvement in limb-girdle muscular dystrophy 2I : conventional cardiac diagnostic and cardiovascular magnetic resonance. J Neurol 253(10):1317–1322PubMedCrossRef
61.
go back to reference Calvo F, Teijeira S, Fernandez JM, Teijeiro A, Fernandez-Hojas R, Fernandez-Lopez XA, Martin E, Navarro C (2000) Evaluation of heart involvement in gamma-sarcoglycanopathy (LGMD2C). A study of ten patients. Neuromuscul Disord 10(8):560–566 Calvo F, Teijeira S, Fernandez JM, Teijeiro A, Fernandez-Hojas R, Fernandez-Lopez XA, Martin E, Navarro C (2000) Evaluation of heart involvement in gamma-sarcoglycanopathy (LGMD2C). A study of ten patients. Neuromuscul Disord 10(8):560–566
62.
go back to reference Wahbi K, Meune C, el Hamouda H, Stojkovic T, Laforêt P, Bécane HM, Eymard B, Duboc D (2008) Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study. Neuromuscul Disord 18(8):650–655PubMedCrossRef Wahbi K, Meune C, el Hamouda H, Stojkovic T, Laforêt P, Bécane HM, Eymard B, Duboc D (2008) Cardiac assessment of limb-girdle muscular dystrophy 2I patients: an echography, Holter ECG and magnetic resonance imaging study. Neuromuscul Disord 18(8):650–655PubMedCrossRef
63.
go back to reference Heller SA, Shih R, Kalra R, Kang PB (2020) Emery-dreifuss muscular dystrophy. Muscle Nerve 61(4):436–448PubMedCrossRef Heller SA, Shih R, Kalra R, Kang PB (2020) Emery-dreifuss muscular dystrophy. Muscle Nerve 61(4):436–448PubMedCrossRef
64.
go back to reference Wang S, Peng D (2019) Cardiac involvement in Emery-dreifuss muscular dystrophy and related management strategies. Int Heart J 60(1):12–18PubMedCrossRef Wang S, Peng D (2019) Cardiac involvement in Emery-dreifuss muscular dystrophy and related management strategies. Int Heart J 60(1):12–18PubMedCrossRef
65.
go back to reference Smith GC, Kinali M, Prasad SK et al (2006) Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 8(5):723–730 Smith GC, Kinali M, Prasad SK et al (2006) Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 8(5):723–730
66.
go back to reference Marchel M, Madej-Pilarczyk A, Tymińska A, Steckiewicz R, Kochanowski J, Wysińska J, Ostrowska E, Balsam P, Grabowski M, Opolski G (2021) Echocardiographic features of cardiomyopathy in Emery-dreifuss muscular dystrophy. Cardiol Res Pract 2021:8812044PubMedPubMedCentralCrossRef Marchel M, Madej-Pilarczyk A, Tymińska A, Steckiewicz R, Kochanowski J, Wysińska J, Ostrowska E, Balsam P, Grabowski M, Opolski G (2021) Echocardiographic features of cardiomyopathy in Emery-dreifuss muscular dystrophy. Cardiol Res Pract 2021:8812044PubMedPubMedCentralCrossRef
67.
go back to reference Butt K, Ambati S (2020) Atrial arrhythmias in Emery-dreifuss muscular dystrophy: approach to successful ablation. Heart Rhythm Case Rep 6(6):318–321 Butt K, Ambati S (2020) Atrial arrhythmias in Emery-dreifuss muscular dystrophy: approach to successful ablation. Heart Rhythm Case Rep 6(6):318–321
68.
go back to reference Draminska A, Kuch-Wocial A, Szulc M, Zwolinska A, Styczynski G, Kostrubiec M, Hausmanowa-Petrusewicz I, Pruszczyk P (2005) Echocardiographic assessment of left ventricular morphology and function in patients with Emery-dreifuss muscular dystrophy. Int J Cardiol 102(2):207–210PubMedCrossRef Draminska A, Kuch-Wocial A, Szulc M, Zwolinska A, Styczynski G, Kostrubiec M, Hausmanowa-Petrusewicz I, Pruszczyk P (2005) Echocardiographic assessment of left ventricular morphology and function in patients with Emery-dreifuss muscular dystrophy. Int J Cardiol 102(2):207–210PubMedCrossRef
69.
go back to reference Turkbey EB, Gai N, Lima JA, van der Geest RJ, Wagner KR, Tomaselli GF, Bluemke DA, Nazarian S (2012) Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging. Heart Rhythm 9(10):1691–1697PubMedPubMedCentralCrossRef Turkbey EB, Gai N, Lima JA, van der Geest RJ, Wagner KR, Tomaselli GF, Bluemke DA, Nazarian S (2012) Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging. Heart Rhythm 9(10):1691–1697PubMedPubMedCentralCrossRef
70.
71.
go back to reference Lau JK, Sy RW, Corbett A, Kritharides L (2015) Myotonic dystrophy and the heart: a systematic review of evaluation and management. Int J Cardiol 184:600–608PubMedCrossRef Lau JK, Sy RW, Corbett A, Kritharides L (2015) Myotonic dystrophy and the heart: a systematic review of evaluation and management. Int J Cardiol 184:600–608PubMedCrossRef
72.
go back to reference Johnson NE, Heatwole CR (2012) Myotonic dystrophy: from bench to bedside. Semin Neurol 32(3):246–254PubMedCrossRef Johnson NE, Heatwole CR (2012) Myotonic dystrophy: from bench to bedside. Semin Neurol 32(3):246–254PubMedCrossRef
73.
go back to reference De Ambroggi L, Raisaro A, Marchianó V, Radice S, Meola G (1995) Cardiac involvement in patients with myotonic dystrophy: characteristic features of magnetic resonance imaging. Eur Heart J 16(7):1007–1010PubMedCrossRef De Ambroggi L, Raisaro A, Marchianó V, Radice S, Meola G (1995) Cardiac involvement in patients with myotonic dystrophy: characteristic features of magnetic resonance imaging. Eur Heart J 16(7):1007–1010PubMedCrossRef
74.
go back to reference Samanta R, Pouliopoulos J, Thiagalingam A, Kovoor P (2016) Role of adipose tissue in the pathogenesis of cardiac arrhythmias. Heart Rhythm 13(1):311–320PubMedCrossRef Samanta R, Pouliopoulos J, Thiagalingam A, Kovoor P (2016) Role of adipose tissue in the pathogenesis of cardiac arrhythmias. Heart Rhythm 13(1):311–320PubMedCrossRef
75.
go back to reference Chmielewski L, Bietenbeck M, Patrascu A, Rösch S, Sechtem U, Yilmaz A, Florian AR (2019) Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1. Clin Res Cardiol 108(8):857–867PubMedCrossRef Chmielewski L, Bietenbeck M, Patrascu A, Rösch S, Sechtem U, Yilmaz A, Florian AR (2019) Non-invasive evaluation of the relationship between electrical and structural cardiac abnormalities in patients with myotonic dystrophy type 1. Clin Res Cardiol 108(8):857–867PubMedCrossRef
76.
go back to reference McNally EM, Mann DL, Pinto Y, Bhakta D, Tomaselli G, Nazarian S, Groh WJ, Tamura T, Duboc D, Itoh H, Hellerstein L, Mammen PPA (2020) Clinical care recommendations for cardiologists treating adults with myotonic dystrophy. J Am Heart Assoc 9(4):e014006PubMedPubMedCentralCrossRef McNally EM, Mann DL, Pinto Y, Bhakta D, Tomaselli G, Nazarian S, Groh WJ, Tamura T, Duboc D, Itoh H, Hellerstein L, Mammen PPA (2020) Clinical care recommendations for cardiologists treating adults with myotonic dystrophy. J Am Heart Assoc 9(4):e014006PubMedPubMedCentralCrossRef
77.
go back to reference Paunic T, Peric S, Cvitan E, Raspopovic S, Peric M, Mandic Stojmenovic G, Rakocevic Stojanovic V (2017) Routine echocardiography in patients with myotonic dystrophy type 1. J Chin Med Assoc 80(7):408–412PubMedCrossRef Paunic T, Peric S, Cvitan E, Raspopovic S, Peric M, Mandic Stojmenovic G, Rakocevic Stojanovic V (2017) Routine echocardiography in patients with myotonic dystrophy type 1. J Chin Med Assoc 80(7):408–412PubMedCrossRef
78.
go back to reference Garcia R, Labarre Q, Degand B, Ingrand P, Le Gal F, Bonnet B, Delaubier A, Guillou C, Gellen B, Coisne D, Bouleti C, Christiaens L (2017) Apical left ventricular myocardial dysfunction is an early feature of cardiac involvement in myotonic dystrophy type 1. Echocardiography 34(2):184–190PubMedCrossRef Garcia R, Labarre Q, Degand B, Ingrand P, Le Gal F, Bonnet B, Delaubier A, Guillou C, Gellen B, Coisne D, Bouleti C, Christiaens L (2017) Apical left ventricular myocardial dysfunction is an early feature of cardiac involvement in myotonic dystrophy type 1. Echocardiography 34(2):184–190PubMedCrossRef
79.
go back to reference Hermans MC, Faber CG, Bekkers SC, de Die-Smulders CE, Gerrits MM, Merkies IS, Snoep G, Pinto YM, Schalla S (2012) Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 14(1):48PubMedPubMedCentralCrossRef Hermans MC, Faber CG, Bekkers SC, de Die-Smulders CE, Gerrits MM, Merkies IS, Snoep G, Pinto YM, Schalla S (2012) Structural and functional cardiac changes in myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 14(1):48PubMedPubMedCentralCrossRef
80.
go back to reference Petri H, Ahtarovski KA, Vejlstrup N, Vissing J, Witting N, Køber L, Bundgaard H (2014) Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16(1):59PubMedPubMedCentralCrossRef Petri H, Ahtarovski KA, Vejlstrup N, Vissing J, Witting N, Køber L, Bundgaard H (2014) Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson 16(1):59PubMedPubMedCentralCrossRef
81.
go back to reference Dutka DP, Donnelly JE, Nihoyannopoulos P, Oakley CM, Nunez DJ (1999) Marked variation in the cardiomyopathy associated with Friedreich’s ataxia. Heart 81(2):141–147PubMedPubMedCentralCrossRef Dutka DP, Donnelly JE, Nihoyannopoulos P, Oakley CM, Nunez DJ (1999) Marked variation in the cardiomyopathy associated with Friedreich’s ataxia. Heart 81(2):141–147PubMedPubMedCentralCrossRef
82.
go back to reference Tanaka H (2021) Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain. J Echocardiogr 19(2):71–79PubMedPubMedCentralCrossRef Tanaka H (2021) Efficacy of echocardiography for differential diagnosis of left ventricular hypertrophy: special focus on speckle-tracking longitudinal strain. J Echocardiogr 19(2):71–79PubMedPubMedCentralCrossRef
83.
go back to reference Lynch DR, Regner SR, Schadt KA, Friedman LS, Lin KY, St John Sutton MG (2012) Management and therapy for cardiomyopathy in Friedreich’s ataxia. Expert Rev Cardiovasc Ther 10(6):767–777PubMedCrossRef Lynch DR, Regner SR, Schadt KA, Friedman LS, Lin KY, St John Sutton MG (2012) Management and therapy for cardiomyopathy in Friedreich’s ataxia. Expert Rev Cardiovasc Ther 10(6):767–777PubMedCrossRef
84.
go back to reference Weidemann F, Störk S, Liu D, Hu K, Herrmann S, Ertl G, Niemann M (2013) Cardiomyopathy of Friedreich ataxia. J Neurochem 126(Suppl 1):88–93PubMedCrossRef Weidemann F, Störk S, Liu D, Hu K, Herrmann S, Ertl G, Niemann M (2013) Cardiomyopathy of Friedreich ataxia. J Neurochem 126(Suppl 1):88–93PubMedCrossRef
85.
go back to reference Dedobbeleer C, Rai M, Donal E, Pandolfo M, Unger P (2012) Normal left ventricular ejection fraction and mass but subclinical myocardial dysfunction in patients with Friedreich’s ataxia. Eur Heart J Cardiovasc Imaging 13(4):346–352PubMedCrossRef Dedobbeleer C, Rai M, Donal E, Pandolfo M, Unger P (2012) Normal left ventricular ejection fraction and mass but subclinical myocardial dysfunction in patients with Friedreich’s ataxia. Eur Heart J Cardiovasc Imaging 13(4):346–352PubMedCrossRef
86.
go back to reference Legrand L, Diallo A, Monin ML, Ewenczyk C, Charles P, Isnard R, Vicaut E, Montalescot G, Durr A, Pousset F (2020) Predictors of left ventricular dysfunction in Friedreich’s ataxia in a 16-year observational study. Am J Cardiovasc Drugs 20(2):209–216PubMedCrossRef Legrand L, Diallo A, Monin ML, Ewenczyk C, Charles P, Isnard R, Vicaut E, Montalescot G, Durr A, Pousset F (2020) Predictors of left ventricular dysfunction in Friedreich’s ataxia in a 16-year observational study. Am J Cardiovasc Drugs 20(2):209–216PubMedCrossRef
87.
go back to reference Weidemann F, Rummey C, Bijnens B, Störk S, Jasaityte R, Dhooge J, Baltabaeva A, Sutherland G, Schulz JB, Meier T, Mitochondrial Protection with Idebenone in Cardiac or Neurological Outcome (MICONOS) study group (2012) The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms. Circulation 125(13):1626–1634 Weidemann F, Rummey C, Bijnens B, Störk S, Jasaityte R, Dhooge J, Baltabaeva A, Sutherland G, Schulz JB, Meier T, Mitochondrial Protection with Idebenone in Cardiac or Neurological Outcome (MICONOS) study group (2012) The heart in Friedreich ataxia: definition of cardiomyopathy, disease severity, and correlation with neurological symptoms. Circulation 125(13):1626–1634
88.
go back to reference Takazaki KAG, Quinaglia T, Venancio TD, Martinez ARM, Shah RV, Neilan TG, Jerosch-Herold M, Coelho-Filho OR, França MC Jr (2021) Pre-clinical left ventricular myocardial remodeling in patients with Friedreich’s ataxia: a cardiac MRI study. PLoS ONE 16(3):e0246633PubMedPubMedCentralCrossRef Takazaki KAG, Quinaglia T, Venancio TD, Martinez ARM, Shah RV, Neilan TG, Jerosch-Herold M, Coelho-Filho OR, França MC Jr (2021) Pre-clinical left ventricular myocardial remodeling in patients with Friedreich’s ataxia: a cardiac MRI study. PLoS ONE 16(3):e0246633PubMedPubMedCentralCrossRef
Metadata
Title
Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging
Authors
Georgios M. Alexandridis
Efstathios D. Pagourelias
Nikolaos Fragakis
Maria Kyriazi
Efthymia Vargiami
Dimitrios Zafeiriou
Vassilios P. Vassilikos
Publication date
20-07-2022

Other articles of this Issue 6/2022

Heart Failure Reviews 6/2022 Go to the issue